Published in Vaccine Weekly, October 20th, 2004
"Amyloid plaques associated to Alzheimer disease present a high content of zinc ions. We previously showed that the N-terminal region of the amyloid peptide A-beta constitutes an autonomous zinc-binding domain. This region encompasses the previously identified epitope A-beta(4-10) targeted by antibodies capable to reduce amyloid deposition, but the influence of A-beta/Zn binding on the epitope recognition remains unknown," investigators in France report.
"We demonstrate here the effect of Zn2+ ions on the recognition of peptides...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Vaccine Weekly